Novo Nordisk deploys extensive legal resources designed to minimize liability and delay resolutions: Teams of experienced MDL defense lawyers from elite firms specializing in pharmaceutical litigation Unlimited financial resources to fund lengthy litigation, hire top medical experts, and pursue every available defense strategy Sophisticated damage minimization strategies that challenge causation, pre-existing conditions, and alternative explanations for injuries Coordinated national defense strategy ensuring consistency across all pending Ozempic cases in the MDL Access to regulatory experts and FDA documentation to argue that label warnings were adequate at the time of prescription Defense counsel in pharmaceutical MDLs typically file Daubert motions challenging the admissibility of plaintiff expert testimony, arguing that the scientific evidence doesnt support causation between the drug and claimed injuries

The dietary strategies outlined in this guide apply to both medications, but tirzepatide users may need to be even more aggressive about small, frequent meals during the adjustment phase
Qiao YL, et al
Evidence for whether GLP-1 receptor agonists can penetrate the BBB remains limited as it has been argued that brain capillary binding or sequestration may not have been accounted for [29]
Benjamin Boury-Jamot, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland Updates Copyright 2018 Delhey, Tippett, Rose, Bennuri, Slattery, Melnyk, James and Frye